Wurm, Raphael
Arfsten, Henrike
Muqaku, Besnik
Ponleitner, Markus
Bileck, Andrea
Altmann, Patrick
Rommer, Paulus
Seidel, Stefan
Hubner, Pia
Sterz, Fritz
Heinz, Gottfried
Gerner, Christopher
Adlbrecht, Christopher
Distelmaier, Klaus
Funding for this research was provided by:
Magistrat der Stadt Wien (19061)
Oesterreichische Nationalbank (15959)
Österreichische Kardiologische Gesellschaft (2014)
Article History
Received: 20 March 2021
Accepted: 19 July 2021
First Online: 3 August 2021
Conflicts of interest
: RW, KD, and CA share a patent for the application of the proteomically identified markers. The other authors declare no conflicts of interest.
: The study was approved by the institutional review board of the Medical University of Vienna (EK 1740/2013), and the primary trial was registered with ClinicalTrials.gov on October 8th, 2013 (ClinicalTrials.gov ref. NCT01960699). In case of awakening, written informed consent was retroactively obtained.